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Unbiased genome-wide screens combined with imaging data on brain function may identify
novel molecular pathways related to human cognition. Here we performed a dense genome-
wide screen to identify episodic memory-related gene variants. A genomic locus encoding the
brain-expressed beta-catenin-like protein 1 (CTNNBL1) was significantly (P=7 108) asso-
ciated with verbal memory performance in a cognitively healthy cohort from Switzerland
(n=1073) and was replicated in a second cohort from Serbia (n=524; P=0.003). Gene
expression studies showed CTNNBL1 genotype-dependent differences in beta-catenin-like
protein 1 mRNA levels in the human cortex. Functional magnetic resonance imaging in 322
subjects detected CTNNBL1 genotype-dependent differences in memory-related brain
activations. Converging evidence from independent experiments and different methodological
approaches suggests a role for CTNNBL1 in human memory.
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Introduction
Searching for molecules related to human cognition
is instrumental for understanding the biological
mechanisms related to such complex traits as memory
capacity and for identifying pathways possibly amen-
able to pharmacological interventions. Recent
advances in the development of high-density geno-
typing platforms allow for high-resolution genome-
wide association studies (GWAS) of genetically
complex traits and have already led to a substantial
increase in knowledge of the genetic underpinnings
of physiological and pathological conditions of
human cognition.1 Such studies can be performed
using both pooled and individual DNA samples.2
Pooled GWAS followed by individual genotyping of
the most significant variants of the DNA pools are a
cost-effective way to perform genome-wide surveys in
large cohorts. Although pooled GWAS may be a
worthwhile and fast approach as a preliminary
screen, they lack the ability of retrospectively stratify-
ing the genotyped pooled cohort by secondary
phenotypic traits and control variables.2
Here we performed a GWAS in individual DNA
samples in a homogenous cohort of Swiss healthy
young adults (n=1198) assessed for verbal episodic
memory performance, as quantified by an unexpected
delayed free-recall test of 30 previously learned words
(see Materials and methods). Single-nucleotide poly-
morphisms (SNPs) surpassing genome-wide correc-
tion for multiple comparisons were analyzed in an
independent sample of healthy young adults from
Serbia (n=524), who were also characterized for
verbal episodic memory performance. To further
validate the genetic findings of the behavioral studies
we analyzed data from studies on gene expression in
human post-mortem brain tissue and also used
functional magnetic resonance imaging (fMRI), which
can detect genotype-dependent differences in brain
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activations during cognitive tasks.3 We show that
variants of CTNNBL1 (encoding beta-catenin-like
protein 1) are consistently associated with episodic
memory performance, with mRNA expression levels
of CTNNBL1 in the human cortex, and with activation
in episodic memory-related brain regions.
Materials and methods
Memory testing
Zurich sample (GWAS subsample 1): We recruited
709 healthy, young Swiss university students or age-
matched employees/trainees (521 females, 188
males). Age was 21.9±0.1 years (mean±s.e.). After
complete description of the study to the subjects,
written informed consent was obtained. The ethics
committee of the Canton of Zurich, Switzerland,
approved the study protocol. Subjects viewed six
series of five semantically unrelated nouns presented
at a rate of one word per second with the instruction
to learn the words for immediate free recall after each
series. In addition, subjects underwent an unexpected
delayed free-recall test of the learned words after
5min (episodic memory). The number of correctly
recalled words (hits) was the relevant output. Atten-
tion and concentration were assessed with the d2
cancellation test4 and working memory with the digit
span task (forward)5 in a subset of the Zurich sample.
In the d2 test, items consist of the letters d and p with
one to four dashes, arranged either individually or in
pairs above and below the letter. Subjects were
instructed to scan, in a timed manner, across each
letter line to identify and delete each d with two
dashes. In the digit span test (forward), increasing
numbers of orally presented digits at a rate of one per
second had to be repeated in the same order. The test
started with three digits. In every other trial the
number of digits was increased by one. When errors
in two consecutive trials were made, the test was
ended and the number of correctly recalled trials was
counted.
In addition to the behavioral tasks, all subjects were
tested with a standardized mental health question-
naire for current and lifetime major psychiatric
diseases, smoking and the use of any medication.
Subjects also provided information on possible
familiar aggregation of major psychiatric diseases,
and female participants also gave information on the
use of oral contraceptives and the actual menstrual
cycle. None of these control variables affected the
results presented herein. Blood was drawn by using
2 9ml EDTA tubes (Sarstedt, Germany). Saliva was
collected with the Oragene DNA sample collection kit
(DNA Genotek, ON, Canada). DNA isolation was done
according to standard protocols.
Basel sample (GWAS subsample 2): We recruited
489 healthy, young Swiss university students or age-
matched employees/trainees (324 females, 165
males). Age was 22.5±0.1 years. After complete
description of the study to the subjects, written
informed consent was obtained. The ethics committee
of the Canton of Basel, Switzerland, approved the
study protocol. Subjects viewed six series of five
semantically unrelated nouns presented at a rate of
one word per second with the instruction to learn the
words for immediate free recall after each series. The
number of correctly recalled words (hits) after 5min
was the relevant output. All subjects were tested with
a standardized mental health questionnaire for cur-
rent and lifetime major psychiatric diseases, smoking
and the use of any medication. In addition, subjects
provided information on possible familiar aggregation
of major psychiatric diseases, and female participants
also gave information on the use of oral contra-
ceptives and the actual menstrual cycle. In addition to
the word-based episodic memory task, 872 subjects
from GWAS samples 1 and 2 performed a picture-
based episodic memory task (see this task’s descrip-
tion in the fMRI experiment section). Saliva was
collected with the Oragene DNA sample collection kit
(DNA Genotek). DNA isolation was done according to
standard protocols.
Serbian sample (replication sample): Study parti-
cipants were 524 healthy young subjects (353 female
and 171 male students of the School of Medicine of
the University of Belgrade, age 20.3±0.04 years) who
agreed to participate in a study of the genetic basis of
human cognition and gave informed consent. Free
recall of a short story narrative (immediate and 30min
delayed recall of items from Story A of the Logical
Memory test; Wechsler Memory Scale-revised)5 was
used to assess verbal memory performance. Working
memory performance was assessed with the Digit
Ordering Task,6 verbal fluency with a category (fruits
and vegetables) verbal fluency task7 and visuospatial
abilities with the Hooper Visual Organization Test.8
Subjects also completed a questionnaire related to
general health, living circumstances, parental educa-
tion and subjective learning capacity.
GWAS statistics, population structure and imputation
GWAS and the replication study were run under the
assumption of an additive model. False discovery rate
(FDR) and correction for 582 514 comparisons were
used to adjust for genome-wide multiple testing. The
FDR and corrected significance levels were set to
5%. Golden Helix SNP and Variation Suite 7 (SVS7,
version 7.3.1; Golden Helix, Bozeman, MT, USA) and
SPSS 17 were used for statistical analyses and visuali-
zation of results.
Population stratification was assessed with EIGEN-
STRAT9 by analyzing all genome-wide, array-based
autosomal SNPs passing quality control (QC) criteria.
Principal component analysis was first applied to
reduce genetic variation to a few dimensions. For
principal component analysis, default parameters
were used (that is, definition of ten principal
components in five iterations, outlier criterion was
6 s.d.). We also applied the Genomic Control program
that is implemented in the EIGENSTRAT package to
compute the inflation factor l10 before and after
removal of the individuals identified as outliers. In
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the total GWAS sample, l was low (l=1.017), while
EIGENSTRAT identified 125 participants deviating
from a large genetically homogenous population
cluster. After outlier removal, l indicated the absence
of population stratification in both subsamples
(lZurich = 1.001, lBasel = 1.000; Supplementary Figure 1).
All SNPs in the CTNNBL1 region reported in the
latest release of the 1000 Genomes project
(www.1000genomes.org) and in the CEU sample in
HapMap Phase II were imputed and analyzed with
IMPUTE,11 which aligns SNPs between haplotype
and genotype databases on the basis of base-pair
position. The quality criterion for inclusion and
subsequent analysis of an imputed SNP was set to
proper_info X0.5.11
Array-based SNP genotyping, SNP filtering
Samples were processed as described in the Genome-
Wide Human SNP Nsp/Sty 6.0. User Guide (Affyme-
trix, Santa Clara, CA, USA). Briefly, genomic DNA
concentration was determined by using a Nano-Drop
ND-1000 and adjusted to 50ngml1 in water. A
quantity of 250ng of DNA was digested in parallel
with 10 units of StyI and NspI restriction enzymes
(New England Biolabs, Beverly, MA, USA) for 2h at
37 1C. Enzyme-specific adaptor oligonucleotides were
then ligated onto the digested ends with T4 DNA
ligase for 3h at 16 1C. After adjustment to 100ml with
water, 10ml of the diluted ligation reactions were
subjected to PCR. Three PCR reactions of 100ml were
performed for Sty-digested products and four PCR
reactions for Nsp. PCR was performed with Titanium
Taq DNA Polymerase (Clontech, Mountain View,
CA, USA) in the presence of 4.5 mM PCR primer 002
(Affymetrix), 350mM each dNTP (Clontech), 1M G-C
Melt (Clontech), and 1 Titanium Taq PCR buffer
(Clontech). Cycling parameters were as follows: initial
denaturation at 94 1C for 3min, amplification at 94 1C
for 30 s, 60 1C for 45 s and extension at 68 1C for 15 s
repeated a total of 30 times, final extension at 68 1C for
7min. Reactions were then verified to migrate at an
average size between 200 and 1100 bp using 2% Tris-
borate-EDTA (TBE) gel electrophoresis. PCR products
were combined and purified with the Filter Bottom
Plate (Seahorse Bioscience, North Billerica, MA,
USA) using Agencourt Magnetic Beads (Beckman
Coulter, Fullerton, CA, USA). Purified PCR products
were quantified on a Zenith 200rt microplate reader
(Anthos-Labtec, Cambridge, UK). A quantity of 4–
5 mgml1 were obtained on average for each sample.
From this stage on, the SNP Nsp/Sty 5.0/6.0 Assay Kit
(Affymetrix) was used. Around 250mg of purified PCR
products were fragmented using 0.5 units of DNAse I
at 37 1C for 35min. Fragmentation of the products to
an average size less than 180bp was verified using 4%
TBE gel electrophoresis. Following fragmentation, the
DNA was end labeled with 105 units of terminal
deoxynucleotidyl transferase at 37 1C for 4h. The
labeled DNAwas then hybridized onto Genome-Wide
Human SNP 6.0 Array at 50 1C for 18h at 60 r.p.m. The
hybridized array was washed, stained and scanned
according to the manufacturer’s (Affymetrix) instruc-
tions using Affymetrix GeneChip Command Console
(version 3.0.1.1214). Generation of SNP calls and
Array QC were performed using the command line
programs of the Affymetrix Power Tools package
(version: apt-1.12.0). According to the manufacturer’s
recommendation, contrast QC was chosen as QC
metric, using the default value of greater or equal
than 0.4. Mean call rate for all samples averaged
98.5%. All samples passing QC criteria were subse-
quently genotyped using the Birdseed (v2) algorithm.
A total of 909 600 SNPs were genotyped and imported
into Golden Helix SNP and Variation Suite 7 (version
7.3.0). For association testing, 19 162 markers with
fewer than two alleles, 38 218 markers with call rate
< 0.95, 220 877 markers with minor allele frequency
<0.05 and 113918 markers with Hardy–Weinberg
equilibrium P<0.05 were skipped leaving a total of
582 514 markers to be analyzed.
Singleplex SNP genotyping
Singleplex genotyping for rs16986890 was done with
Pyrosequencing on a PyroMarkID System (QIAGEN,
Hilden, Germany). Forward primer: 50-TCCTGGATCT
TGGCCTTTACAT-30; reverse primer (50-biotinylated):
50-GTGCAACCAACATATTTGCATTT-30; sequencing
primer: 50-TCTATTGTATCTGAGGGTTC-30. The
chip-based SNP_A-1909171 (rs16986890) was also
genotyped by Pyrosequencing in the Zurich sample.
The level of convergence between array- and pyro-
sequencing-based genotype calls was 100%.
Cortical gene expression
Data are based on the survey of genetic human
cortical gene expression published by Myers et al.12
Gene expression studies of 178 samples from the
cerebral cortex of neurpathologically normal brains
were done with the Illunima (San Diego, CA, USA)
HumanRefseq-8 Expression BeadChip. For genome-
wide genotyping, the Affymetrix GeneChip Human
Mapping 500K Array Set was used. The complete
data files were downloaded from http://labs.med.-
miami.edu/myers/. CTNNBL1 transcript probe was
GI_29570786 (NM_030877.3), and expression levels
of GI_29570786 were used as dependent variable.
fMRI experiment
Participants. A total of 322 healthy young subjects
(mean age 22.5±0.2 years, range 18–34 years; 193
females; 290 AA genotype carriers of SNP rs16986890;
29 AG genotype carriers of SNP rs16986890, 3 GG
genotype carriers of SNP rs16986890) were included in
the study. All subjects were right-handed, free of any
lifetime neurological or psychiatric illness, and did not
take any medication at the time of the experiment. The
experiments were approved by the ethics committee of
the University of Basel. Written informed consent was
obtained from all subjects prior to participation.
Picture task. Stimuli consisted of 72 pictures that
were selected from the International Affective
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Picture System (IAPS)13 as well as from in-house
standardized picture sets that allowed us to equate
the pictures for visual complexity and content (for
example, human presence). On the basis of normative
valence scores (from 1 to 9), pictures were assigned to
emotionally negative (2.3±0.6), emotionally neutral
(5.0±0.3) and emotionally positive (7.6±0.4) condi-
tions, resulting in 24 pictures for each emotional
valence. Four additional pictures showing neutral
objects were used to control for primacy and recency
effects in memory. Two of these pictures were
presented in the beginning and two at the end of the
picture task. They were not included in the analysis. In
addition, 24 scrambled pictures were used. The
background of the scrambled pictures contained the
color information of all pictures used in the experiment
(except primacy and recency pictures), overlaid with
a crystal and distortion filter (Adobe Photoshop CS3,
Adobe Systems Inc., San Jose, CA, USA). In the
foreground, a mostly transparent geometrical object
(rectangle or ellipse of different sizes and orientations)
was shown. Pictures were presented in the scanner
using MR-compatible LCD goggles (Visuastim XGA,
Resonance Technology, Los Angeles, CA, USA). Eye
correction was used when necessary.
Encoding phase. The pictures were presented for 2.5 s
in a quasi-randomized order so that at maximum
four pictures of the same category occurred
consecutively. A fixation-cross appeared on the screen
for 500ms before each picture presentation. Trials were
separated by a variable intertrial period of 9–12s (jitter)
that was equally distributed for each stimulus category.
During the intertrial period, participants subjectively
rated the picture showing scenes according to valence
(negative, neutral, positive) and arousal (large, medium,
small) on a three-point scale (Self-Assessment Manikin)
by pressing a button with a finger of their dominant
hand. For scrambled pictures, participants rated form
(vertical, symmetric or horizontal) and size (large,
medium, small) of the geometrical object in the
foreground. The encoding phase of the picture had
a total duration of 22min. Participants were not told
that they had to remember the pictures for later
recall. Participants were instructed and trained on the
picture task before being positioned in the scanner.
Training consisted of presentation and rating of five
pictures including scenes and scrambled pictures,
which were not used during scanning. Free recall:
10min after picture presentation, memory performance
was tested using a free-recall task, which required
participants to write down a short description of
the previously seen pictures. Remembered primacy
and recency pictures as well as training pictures
were excluded from the analysis. No time limit was
set for this task. Two trained investigators indepen-
dently rated the descriptions for recall success (inter-
rater reliability >99%).
Procedure. After receiving general information about
the study and giving their informed consent,
participants were instructed and then trained on the
picture task they later performed in the scanner. After
training, they were positioned in the scanner. The
participants received earplugs and headphones to
reduce scanner noise. Their head was fixated in the
coil using small cushions, and they were told not to
move their heads. Functional MR images were
acquired during the performance of the picture task
in two separate sessions (total scanning time
B30min). After finishing the tasks, participants left
the scanner and were taken to a separate room for free
recall of the pictures. Finally, participants filled out
questionnaires, gave saliva for genotype analysis and
were debriefed. The total length of the experimental
procedure was B3h. Participants received 25Swiss
Francs (CHF)per hour for participation.
fMRI data acquisition and processing. Measurements
were performed on a Siemens (Munich, Germany)
Magnetom Verio 3T whole-body MR unit equipped
with a twelve-channel head coil. Functional time
series were acquired with a single-shot echo-planar
sequence using parallel imaging (GRAPPA). We
used the following acquisition parameters: TE (echo
time) = 35ms, FOV (field of view) = 22 cm, acquisition
matrix = 80 80, interpolated to 128128, voxel size:
2.75 2.75 4mm3, GRAPPA acceleration factor
R=2.0. Using a midsaggital scout image, 32 conti-
guous axial slices were placed along the anterior–
posterior commissure plane covering the entire brain
with a TR=3000ms (a=821). The first two acquisi-
tions were discarded due to T1 saturation effects.
Preprocessing and data analysis was performed
using SPM5 (Statistical Parametric Mapping, Well-
come Department of Cognitive Neurology, London,
UK; http://www.fil.ion.ucl.ac.uk/spm/) implemented
in Matlab 2008a (The Mathworks, Natick, MA, USA).
Volumes were slice-time corrected to the first slice,
realigned to the first acquired volume, normalized
into standard stereotactic space (template provided by
the Montreal Neurological Institute), and smoothed
using a 8-mm full-width-at-half-maximum Gaussian
kernel. A 128 s cut-off high-pass filter was added to
the confound partition of the design matrix to account
for low-frequency drifts, and a correction for intrinsic
autocorrelations was included in the analysis. For
each subject, evoked hemodynamic responses to
event types were modeled with a delta (stick)
function corresponding to presentation of each sti-
mulus category (negative, positive, neutral and
scrambled pictures, respectively) convolved with a
canonical hemodynamic response function within
the context of a general linear model. The pictures
accounting for possible primacy and recency effects
as well as button presses during valence and arousal
ratings were modeled separately. In addition, six
movement parameters from spatial realigning were
included as regressors of no interest. The contrast
between brain activity during encoding of pictures
subsequently remembered versus pictures subse-
quently forgotten was calculated individually
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using a fixed-effects model (first-level analysis).
The resulting contrast parameters were then used for
genotype-dependent analyses in a random-effects
model (second-level analysis). Specifically, we used
a regression model to analyze gene–dose-dependent
differences in brain activity (with the number of
G-alleles as covariate) and two-sample t-tests to
analyze genotype-dependent differences under the
dominant model (GG vs [AG and AA]).
For genotype-independent analyses, we used a
threshold of P<0.05, Family-Wise Error (FWE)-cor-
rected for multiple comparisons in the whole brain.
For genotype-dependent analyses, we used an uncorr-
ected threshold of P<0.001 in a minimum number of
10 adjacent voxels (k=10) for an exploratory analysis
of the whole brain.
Results
Genome-wide survey and replication study
All samples (n=1198) were processed on the Affyme-
trix Genome-Wide Human SNP Array 6.0 in one
centralized microarray facility. After standard QC and
correction for minor allele frequency and deviation
from Hardy–Weinberg equilibrium (see Materials and
methods), a total of 582 514 out of the 909 600 array
SNPs were used for association analyses under an
additive model. Analysis of genetic background in the
GWAS sample showed that the level of population
stratification was low (l=1.017). Principal compo-
nent analysis using all available autosomal array
markers passing QC identified 125 participants
deviating from one large population cluster (see
Materials and methods, Supplementary Figure 1).
Omission of these subjects from the analysis led to
an ideal population structure (l=1.000). There-
fore, genome-wide association analyses were done
with the remaining 1073 participants. CTNNBL1
marker SNP rs16986890 reached the highest level of
statistical significance for association with verbal
episodic memory and survived both FDR correc-
tion and correction for 582 514 multiple comparisons
(Pnominal = 7.7108, PFDR = 0.002, Pcorrected = 0.046;
Table 1; Figure 1; Supplementary Tables 1 and 4).
The effect size (ES) of SNP rs16986890 was small and
thereby within the expected range of small ESs
observed in genetic studies of polygenic behavioral
traits (Table 1). This SNP was additionally genotyped
on a different, singleplex platform to prevent false
interpretations due to possible array-related geno-
typing errors (see Materials and methods). The level
of convergence between array- and singleplex-based
genotype calls was 100%. Because the GWAS popu-
lation consisted of two subsamples, each recruited
independently in a different Swiss city (Zurich,
n=625; Basel, n=448), we performed a post-hoc
analysis to rule out possible recruitment location-
related bias. The additive effect on episodic memory
was observed in both subsamples (Table 1) and
showed no significant SNP  sample interaction
(P=0.9).
The significance of association rapidly decreased
with increasing distance from the CTNNBL1 locus
and did not extend to nearby loci (Figure 1;
Supplementary Table 1). To better characterize the
profile of the association signal we used data from the
1000 Genomes project (www.1000genomes.org) and
reinvestigated this region using imputation, which
allowed for analysis of virtually all common SNPs in
this region and offered a sevenfold increase in marker
density over the 6.0 array SNPs. Imputation analysis
confirmed the initially observed pattern of association
with highly significant intragenic SNPs and SNPs
adjacent to CTNNBL1 and rapid decrease in signifi-
cance with increasing distance from the CTNNBL1
locus (Supplementary Figure 2).
To study possible pleiotropic effects of rs16986890
on cognition, we additionally analyzed this SNP’s
effects on immediate recall, working memory and
attention (see Materials and methods; Supplementary
Table 2). No significant associations with the outcome
of these cognitive tasks were observed. These findings
suggest that the CTNNBL1 genotype–dependent dif-
ferences in episodic memory processes were not
biased by genotype effects on attention and short-
term memory.
Quantile–quantile plotting and analysis further
supported the robustness of the initial finding in
Table 1 Genotype-dependent performance in word-based episodic memory tasksa in the GWAS sample (Switzerland, n=1073)
and the replication sample (Serbia, n=524)








n Mean±s.e.m. n Mean±s.e.m. n Mean±s.e.m. n Mean±s.e.m.
AA 961 0.05±0.03 564 0.04±0.04 397 0.07±0.04 434 0.14±0.06
AG 106 0.41±0.11 59 0.39±0.14 47 0.43±0.17 88 0.37±0.16
GG 6 1.06±0.37 2 0.75±0.00 4 1.21±0.57 2 0.84±0.70
P=0.00000007
ES: d=0.33; r2= 0.027
P=0.0005
ES: d=0.28; r2= 0.019
P=0.00003
ES: d= 0.39; r2=0.038
P=0.003
ES: d=0.26; r2 = 0.017
Abbreviations: d, Cohen’s d; ES, effect size; GWAS, genome-wide association study.
aNOTE: Values are z-transformed to allow direct comparison between samples.
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the GWAS sample. Over 99.999% of the P-values
distributed in accordance with random expectation,
suggesting that the GWAS results are most likely to be
attributable to true genetic variation rather than to
potential bias, such as genotyping errors or popula-
tion stratification (Supplementary Figure 3). The
significant association between CTNNBL1 SNP
rs16986890 and episodic memory performance was
replicated in a sample of 524 healthy young adults
from Belgrade, Serbia (P=0.003; additive model and
direction of effect as in the GWAS sample; Table 1).
Also in this sample, rs16986890 was not associated
with performance in tasks quantifying working
memory performance, verbal fluency and visuospatial
abilities (all P-values >0.3; see Materials and methods;
Supplementary Table 3). In addition to SNP
rs16986890, the nine most significant SNPs of the
Swiss sample, which were not in tight linkage
disequilibrium (LD) (that is, r2 <0.8) with rs16986890,
were tested for replication in the Serbian sample
(Supplementary Table 5). Four out of ten tested SNPs
(including rs16986890) were nominally significantly
associated with episodic memory also in the Serbian























































1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 x
Figure 1 Genome-wide association results. (a) Genome-wide significances (Y axis, log10P) are shown in chromosomal
order for individually genotyped SNPs that were tested for association with word-based episodic memory performance in
1073 healthy Swiss young adults. (b) Zoom-in of the association results (Y axis, log10P) to a region of chromosome 20q11.23
harboring the CTNNBL1 locus. Chromosomal positions were retrieved from the March 2006 UCSC genome browser assembly.
(c) LD structure (r2-values) of the chromosomal region shown in panel b as calculated in the entire sample of 1073 healthy
Swiss young adults. Known transcripts in this region are visualized in the lower part. The red arrow indicates the position of
rs16986890, which is located in the first intron of CTNNBL1.
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Genetic association with cortical gene expression
SNP rs16986890 is located in the 50 end of CTNNBL1
exon 1 and is tightly linked to 50 untranslated region
variants (Figure 1, Supplementary Figure 1). To study
the possible relation of CTNNBL1 polymorphisms
with mRNA expression levels, we examined the
association between CTNNBL1 SNPs and cortical
expression of the CTNNBL1 transcript GI_29570786
(NM_030877.3) in the brains of 178 non-demented
deceased subjects (see Materials and methods). A
subset of CTNNBL1 SNPs reported in our genetic
study of human memory performance is also repre-
sented on the lower marker density 500 k SNP Array
set, which was used in the study of cortical gene
expression. SNP rs16986890 was not analyzed due to
insufficient minor allele frequency ( < 0.05) in this
sample. We therefore analyzed SNP rs7363432, which
was the closest, tightly linked SNP (expectation-
maximization (EM) r2 = 0.89) with minor allele fre-
quency X0.05 (154 AA carriers, 23 AG carriers, 1 GG
carrier; Hardy–Weinberg equilibrium, P=0.88). Com-
parison between genotype groups revealed signifi-
cantly elevated levels of CTNNBL1 mRNA in AG
compared with AA carriers (312.7±11.8 vs
289.2±4.0, respectively; T=2.1, d.f. = 175, P=0.037;
due to low number of observations (n=1) GG
genotypes were omitted from statistical analysis).
Thus, in the post-mortem gene expression sample,
RNA expression levels of CTNNBL1were increased in
minor allele carriers of rs7363432. Interestingly, SNP
rs7363432 was among the most significant SNPs in
the Swiss GWAS sample (episodic memory, n=1073,
P=0.0000015; Supplementary Table 1), with minor
allele carriers showing better memory performance.
Genetic variability within CTNNBL1 is linked to
human brain function
The above-described behavioral genetics experiments
used episodic memory tests, which consisted of
delayed free recall of verbal information. In 872 Swiss
participants (a subsample of the above-described
GWAS sample), an additional picture-based episodic
memory task was performed. In this sample,
CTNNBL1 SNP rs16986890 was also associated with
performance in this picture-based memory task, albeit
with lower ES compared with the word-based task.
Specifically, we observed a significant additive effect
of rs16986890 with a positive correlation between the
number of minor alleles and performance during free
recall of pictures (P=0.027; ES: d=0.15, r2 = 0.006). In
322 subjects, this picture-based episodic memory task
was performed during fMRI. This allowed us to
investigate the impact of CTNNBL1 genetic variability
on activity of memory-related brain regions. These
regions were identified by comparing activity during
encoding of subsequently remembered versus subse-
quently forgotten pictures (that is, subsequent mem-
ory analysis). The genotype-independent subsequent
memory analysis revealed several memory-related
brain regions (Supplementary Figure 4), including
prefrontal and parietal regions as well as the hippo-
campus and parahippocampal gyrus—brain regions
known to have an important role in episodic
memory.14,15
In the fMRI sample, there were 290 AA carriers, 29
AG carriers and 3 GG carriers of CTNNBL1 SNP
rs16986890. As expected due to the lower number of
subjects in the fMRI sample (n=322) than in the
behavioral genetics sample (n=872), we did not
observe significant (P>0.05) genotype-dependent dif-
ferences on the behavioral level. Genotype-dependent,
subsequent memory analyses of the fMRI data revealed
significant, whole-brain FDR-corrected, gene dose-
dependent (with increasing number of G-alleles)
increases in activity in the parahippocampal gyrus (peak
activation at [19 30 12]; Pwhole-brain FDRcorrected=0.04,
Pnominal <0.001) and in the medial frontal gyrus/anterior
cingulate (peak activations at [14 55 0]; [30 47 12];
[22 44 4]; Pwhole-brain FDRcorrectedp0.03, Pnom-
inal < 0.001) (Figure 2). There were no other signi-
ficantly increased brain activations in this analysis
and there were no supra-threshold activations
when calculating the negative correlation (with
decreasing number of G-alleles). Reanalysis under
the dominant model (GG vs [AG and AA]) revealed
similar findings.
Discussion
Here we present evidence suggesting that the gene
encoding beta-catenin-like protein 1 (CTNNBL1) has a
significant role in human episodic memory. Specifi-
cally, marker SNPs in the CTNNBL1 locus were
associated with episodic memory performance after
correction for multiple comparisons in a homogenous
and carefully phenotyped sample of Swiss healthy
young adults, and were replicated in an independent
sample of healthy young adults recruited in Belgrade,
Serbia. Furthermore, gene expression analysis in
human post-mortem brain tissue showed that a
Figure 2 CTNNBL1 rs16986890 genotype-depended
differences in memory-related brain activity (subsequent
memory analysis, see main text) in 322 individuals.
Displayed are gene dose-dependent (with increasing num-
ber of G-alleles) increases in activity in the parahippo-
campal gyrus (left figure, coronal section, peak activation at
[19 30 12]; Pwhole-brain FDRcorrected = 0.04, Pnominal < 0.001)
and in the medial frontal gyrus/anterior cingulate (right
figure, sagittal section, peak activation at [14 55 0];
Pwhole-brain FDRcorrected = 0.01, Pnominal < 0.001). Activations
were overlaid on sections of a T1-weighted magnetic
resonance image of SPM5, displayed at an uncorrected
threshold of P=0.001 and using color-coded t-values.
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CTNNBL1 marker associated with better episodic
memory was also associated with higher mRNA levels
of CTNNBL1 in the human cortex. In addition, fMRI
experiments during episodic memory tasks revealed
CTNNBL1 genotype-dependent differences in brain
activations in regions typically involved in episodic
memory processes. The significant marker SNPs are
located either in intronic or in upstream, putatively
regulatory regions of CTNNBL1, which also harbor the
hypothetical LOC100287792.
Recent studies reporting associations of candidate
genes with specific memory-related phenotypes
observed medium to large ESs (for example, SNPs
in BDNF,16 GRM3,17 ADRA2B18). The GWAS sample
of 1073 participants, which was used for unbiased
genome-wide screening in this study, was sufficiently
powered also for the detection of small ES. Assuming
a genetic marker with rather small ES
(0.01pr2p0.05),19 the power of our GWAS sample to
detect associations at a genome-wide-corrected
a-error probability (PFDRp0.05) was B90%. The
power of the replication sample (n=524) to detect
associations with a similarly small ES at an a-error
probability p0.05 was >95%. The actual ESs (r2) in
this study varied between 0.017 and 0.038 (Table 1),
hence they were within the expected range of small
ESs observed in GWAS dealing with polygenic
cognitive traits.
CTNNBL1, which was identified and cloned
recently, spans over 178 kb on human chromosome
20q11.23 (UCSC Genome Browser; GRCh36/hg18
assembly) and contains 16 exons. The encoded
protein (beta-catenin-like protein 1) is a widely
expressed nuclear protein and is highly conserved
in mammals (96% amino acid identity with the
mouse ortholog). Its biological function is not well
understood, however, it seems to be a pleiotropic
protein involved in such important processes as
apoptosis and antibody diversification, and is part
of the spliceosomal complex.20 Moreover, beta-cate-
nin-like protein 1 shares significant structural simi-
larity with the armadillo repeat family of proteins,
including Drosophila melanogaster armadillo protein
and its mammalian ortholog beta-catenin. Beta-cate-
nin is a pleitropic adherens junction protein, which
regulates numerous cellular processes and also func-
tions as a component of the Wnt-signaling pathway.
Beta-catenin regulates numerous neuronal functions;
for example, it is a mediator of dendritic development
through enhancing dendritic arborization.21 In ro-
dents, beta-catenin is required for memory consolida-
tion.22 Interestingly, the results reported herein show
that CTNNBL1 genotypes associated with better
episodic memory performance were also associated
with increased brain activation during encoding of
information and with increased mRNA levels of
CTNNBL1 in the human brain. It is tempting to
speculate that CTNNBL1 acts on human memory via
beta-catenin-related mechanisms. However, it is
hitherto completely unclear, whether beta-catenin-
like protein 1 shares any similar functions with
beta-catenin, especially because both proteins show
only structural, rather than sequence similarity.
Taken together, the present high-density GWAS
followed by a replication study and supported by
gene expression data and fMRI experiments suggests a
role for the beta-catenin-like protein 1 in human
episodic memory. These results demonstrate the
usefulness of unbiased genome-wide approaches
and their potential to identify important and novel
molecular pathways related to human cognition.
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